Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
NPPA brings 44 more essential drugs under price cap
Mint Mumbai
|August 30, 2023
The National Pharmaceutical Pricing Authority (NPPA) has brought 44 new drugs under price control. These drugs are commonly used for pain management, depression, anxiety, gastrorelated ailments, hypertension and several auto-immune diseases.
The move is set to make these drugs cheaper. Manufacturers failing to comply with the price cap have to return the overcharged amount to the government.
The retail price for paroxetine controlled release and clonazepam, a combination drug used for treating mood swings and anxiety, has been fixed at ₹ 14.53 per capsule. Itraconazole capsule, used to treat fungal infections, has been fixed at 12.06.
Denne historien er fra August 30, 2023-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Bank-funded acquisitions won't displace private credit
The Reserve Bank of India's (RBI) draft framework for bank-led acquisition finance marks a decisive policy turn: Indian banks can now enter the acquisition finance market within a clear perimeter, reshaping the competitive dynamics between banks and private credit funds.
3 mins
November 20, 2025
Mint Mumbai
Air India lobbies to use airspace over China's Xinjiang
India-China flights resumed after a five-year hiatus.
1 mins
November 20, 2025
Mint Mumbai
Nitish Kumar to take oath as Bihar CM
JD(U) supremo Nitish Kumar to be sworn-in as Bihar chief minister for a record 10th time.
1 min
November 20, 2025
Mint Mumbai
A fresh perspective on abstraction in art
A new exhibition in Mumbai showcases different approaches to abstraction by artists like Zarina, Seher Shah and Mehlli Gobhai
3 mins
November 20, 2025
Mint Mumbai
Govt eyes post-cut GST revenue surge
FinMin expects Nov GST receipts growth to rebound to 10%
2 mins
November 20, 2025
Mint Mumbai
PayMate pulls plug on West Asia operations
The Visa-backed B2B payments firm is scrambling to raise more funds
2 mins
November 20, 2025
Mint Mumbai
Exide's dual bet: Can lithium-ion offset a weakening core?
Exide Industries Ltd is struggling to fuel its core lead-acid business while simultaneously turning its capex-heavy lithium-ion venture into a viable second growth engine.
1 mins
November 20, 2025
Mint Mumbai
Bank-funded acquisitions won’t displace private credit
The Reserve Bank of India's (RBI) draft framework for bank-led acquisition finance marks a decisive policy turn: Indian banks can now enter the acquisition finance market within a clear perimeter, reshaping the competitive dynamics between banks and private credit funds.
3 mins
November 20, 2025
Mint Mumbai
Afghanistan trade minister seeks India investments, goods
Afghanistan's Taliban trade minister arrived in India on Wednesday on a maiden visit to draw greater investments and goods as both countries consider ways to enhance their relations in the backdrop of souring relations with neighboring Pakistan.
1 min
November 20, 2025
Mint Mumbai
Fractal Analytics bets heavily on R&D in AI race before IPO
Enterprise artificial intelligence firm Fractal Analytics plans to maintain high research and development (R&D) spending ahead of its market debut for which a date has not yet been set, a top executive has said.
2 mins
November 20, 2025
Translate
Change font size